OR WAIT null SECS
© 2022 MJH Life Sciences and BioPharm International. All rights reserved.
© 2022 MJH Life Sciences™ and BioPharm International. All rights reserved.
January 18, 2022
Samsung Biologics is planning to construct a new manufacturing facility in Incheon, South Korea, that will offer multi-product manufacturing, including cell and gene therapies and next-gen vaccines.
January 05, 2022
With this investment into Yapan Bio, Piramal Pharma adds new technologies and capabilities in large molecules, including vaccines and gene therapies, to its global offering.
January 02, 2022
Enhancement of resin technology can improve the ability of chromatography to purify the growing landscape of increasingly complex biomolecules.
December 17, 2021
Genezen has opened its new process development and analytical lab for viral vector production.
December 16, 2021
Pfizer invested $68.5 million in a facility in Durham, NC.
December 13, 2021
SKAN’s new Cellana isolator is designed for GMP manufacturing of ATMPs.
December 10, 2021
Guide addresses challenges of applying GMPs to autologous cell therapy manufacturing.
December 02, 2021
Timing is everything, and it might be ideal for acceleration of real-time monitoring solutions.
November 19, 2021
Scientific innovation and regulatory reformations are helping to drive the global biopharma market forward, but a balance between cost and value still needs to be accepted for widespread adoption.
November 10, 2021
Part 2—Industry experts from MilliporeSigma, Lonza, Astrea Bioseparations, and Sartorius provide insight and examples about solving critical challenges in both analytics and process development for emerging therapies.